Summit Therapeutics Files 8-K on Financials
Ticker: SMMT · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1599298
| Field | Detail |
|---|---|
| Company | Summit Therapeutics Inc. (SMMT) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
Summit Therapeutics filed an 8-K. Financials and operations update.
AI Summary
On February 24, 2025, Summit Therapeutics Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with Regulation FD disclosures and financial statements. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing indicates Summit Therapeutics is providing updates on its financial performance and operational status to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Summit Therapeutics Inc. (company) — Registrant
- February 24, 2025 (date) — Date of Report
- 305-203-2034 (phone_number) — Registrant's Telephone Number
- 601 Brickell Key Drive, Suite 1000, Miami, FL 33131 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by Summit Therapeutics Inc.?
The primary purpose of this 8-K filing is to report on the company's Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on February 24, 2025.
What is the exact name of the company filing this report?
The exact name of the company filing this report is Summit Therapeutics Inc.
What is the principal executive office address for Summit Therapeutics Inc.?
The principal executive office address for Summit Therapeutics Inc. is 601 Brickell Key Drive, Suite 1000, Miami, FL 33131.
What is the telephone number for Summit Therapeutics Inc.?
The telephone number for Summit Therapeutics Inc. is (305) 203-2034.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding Summit Therapeutics Inc. (SMMT).